Ciprofloxacin / Tinidazole Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 500mg + 600mg

Reference Brands: Ciplox-TZ (india), Cipro-TZ (india)

Category: Antibiotics

Ciprofloxacin and Tinidazole Tablet is mainly used for Vaginal or stomach infections, Gums infection, Womb lining infections, Bacterial infections, Skin infections, Infections of the blood, Infections of the skin,Lungs infection, Chest infections, Bacterial infection. Ciprofloxacin / Tinidazole Tablets is available in Tablets and strengths such as 500mg + 600mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ciprofloxacin / Tinidazole Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ciprofloxacin / Tinidazole Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Ciprofloxacin and Tinidazole Tablet contains Ciprofloxacin and Tinidazole as active ingredients mainly. Wellona Pharma’s Ciprofloxacin and Tinidazole Tablet works by inhibiting the DNA formation to prevent the bacterial reproduction; killing bacteria and reducing the infection.

Ciprofloxacin and Tinidazole is a combination antimicrobial therapy that has demonstrated significant clinical effectiveness in the management of inflammatory and infectious gastrointestinal conditions, including pouchitis. Clinical findings indicate that patients treated with this combination show a marked reduction in disease severity, as reflected by decreased Pouchitis Disease Activity Index (PDAI) scores, along with notable improvements in quality of life.

Compared to alternative therapies such as mesalamine, this antibiotic combination has shown superior outcomes, with higher rates of clinical remission and response. The dual mechanism of action—ciprofloxacin targeting aerobic bacteria and tinidazole acting against anaerobic bacteria and protozoa—provides broad-spectrum coverage, contributing to its enhanced therapeutic efficacy.

While generally well tolerated, some patients may experience mild adverse effects such as peripheral neuropathy or altered taste sensation. Overall, this combination remains a valuable treatment option in clinical practice, particularly in cases where mixed infections or inflammatory complications are present, offering both symptom relief and improved patient outcomes.